missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ GABARAPL2 Polyclonal Antibody

Descripción
Reconstitute in 100 μL of sterile water. Centrifuge to remove any insoluble material. After reconstitution keep aliquots at -20 °C for a higher stability, and at 4 °C with an appropriate antibacterial agent. Glycerol (1:1) may be added for an additional stability. Avoid repetitive freeze/thaw cycles.
Involved in intra-Golgi traffic. Modulates intra-Golgi transport through coupling between NSF activity and SNAREs activation. It first stimulates the ATPase activity of NSF which in turn stimulates the association with GOSR1.
Especificaciones
Especificaciones
| Antígeno | GABARAPL2 |
| Aplicaciones | Immunohistochemistry (Frozen), Western Blot |
| Clasificación | Polyclonal |
| Concentración | Conc. Not Determined |
| Conjugado | Unconjugated |
| Formulación | Whole serum with no preservative |
| génica | GABARAPL2 |
| N.º de referencia del gen | P60520, P60522 |
| Alias de gen | 0610012F20Rik; 2900019O08Rik; AI173605; ATG8; ATG8C; FLC3A; GABA type A receptor associated protein like 2; GABA(A) receptor-associated protein like 2; GABA(A) receptor-associated protein-like 2; gabarapl2; gamma-aminobutyric acid (GABA) A receptor-associated protein-like 2; gamma-aminobutyric acid (GABA-A) receptor-associated protein-like 2; gamma-aminobutyric acid receptor-associated protein-like 2; Ganglioside expression factor 2; GATE16; GATE-16; Gef2; GEF-2; Genera; general protein transport factor p16; Golgi-associated ATPase enhancer of 16 kDa; MAP1 light chain 3 related protein; MAP1 light chain 3-related protein; zgc:92319 |
| Símbolos de los genes | GABARAPL2 |
| Mostrar más |
Título del producto
Al hacer clic en Enviar, acepta que Fisher Scientific se ponga en contacto con usted en relación con los comentarios que ha proporcionado en este formulario. No compartiremos su información para ningún otro fin. Toda la información de contacto proporcionada se mantendrá de acuerdo con nuestra Política de Privacidad. Política de privacidad.
¿Detecta una oportunidad de mejora?